Sean Dodge
Stock Analyst at RBC Capital
(2.00)
# 3,120
Out of 4,983 analysts
131
Total ratings
30.93%
Success rate
-2.05%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $2.88 | +108.33% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $1.12 | +212.50% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $186.81 | +44.53% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.87 | +52.48% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $173.13 | +51.91% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $8.64 | +96.76% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $23.50 | +36.17% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $18.12 | -66.89% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $91.54 | +14.70% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $16.30 | +4.29% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $38.25 | -11.11% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $20.75 | -32.53% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.23 | +136.41% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.32 | +25.45% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $15.62 | -10.37% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $193.45 | -82.94% | 1 | Sep 14, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $2.88
Upside: +108.33%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $1.12
Upside: +212.50%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $186.81
Upside: +44.53%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.87
Upside: +52.48%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $173.13
Upside: +51.91%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.64
Upside: +96.76%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $23.50
Upside: +36.17%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $18.12
Upside: -66.89%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $91.54
Upside: +14.70%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $16.30
Upside: +4.29%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $38.25
Upside: -11.11%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $20.75
Upside: -32.53%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.23
Upside: +136.41%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $22.32
Upside: +25.45%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $15.62
Upside: -10.37%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $193.45
Upside: -82.94%